gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Epidermal growth factor receptor

The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jul 2010] (from NCBI)
Top mentioned proteins: HAD, CAN, V1a, AGE, Epidermal Growth Factor
Papers using EGFR antibodies
Studying lipids involved in the endosomal pathway.
Johannes Ludger, In PLoS ONE, 2011
... South San Francisco, CA); EEA1 (Transduction Laboratories); LAMP1 (CD107a; BD Biosciences); EGFR (BD Biosciences); α-tubulin (Sigma- Aldrich) ...
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
Croce Carlo M. et al., In Nature medicine, 2010
... Targeting of both the c-Met and EGFR pathways results in additive inhibition of lung tumorigenesis in transgenic mice ...
Total internal reflection STED microscopy
Bewersdorf Joerg et al., In Biomedical Optics Express, 2010
... A linker encoding the signal sequence of EGFR was inserted into 5′ MCS of pSNAPf vector (New England Biolabs) using the unique NheI ...
Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis.
Gaetano Carlo, In PLoS ONE, 2009
... Materials: The antibodies of VEGF, PEDF, TNF-α, epidermal growth factor receptor (EGFR) were purchased from Abcam, Cambridge, MA, USA ...
Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains.
Caplan Steve H., In PLoS ONE, 2009
... Louis, MO), and mouse anti-EGFR was from Cell signaling technology (Danvers, MA) ...
more suppliers
Papers on EGFR
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.
Hirata et al., Ōsaka, Japan. In Expert Opin Pharmacother, Feb 2016
INTRODUCTION: While epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitors (TKIs) lead to longer progression-free survival (PFS) when compared with conventional chemotherapy in non-small-cell lung cancer (NSCLC) harboring activating EGFR mutations, the role of EGFR-TKI remains unclear in EGFR-wild-type (WT) NSCLC.
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer.
Yang et al., Houston, United States. In Nat Cell Biol, Feb 2016
Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively.
MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.
Blandino et al., Roma, Italy. In Semin Cell Dev Biol, Feb 2016
A special focus will be devoted to epidermal growth factor receptor (EGFR) signaling, a system offering relatively rich information.
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
Sholl et al., Boston, United States. In J Clin Oncol, Feb 2016
Clinical characteristics of MET exon 14 mutated NSCLCs were compared with those of NSCLCs with activating mutations in KRAS and EGFR.
Requirement of Stat3 Signaling in the Postnatal Development of Thymic Medullary Epithelial Cells.
Kawamoto et al., Yokohama, Japan. In Plos Genet, Jan 2016
Activation of Stat3 is mainly positioned downstream of EGF-R as its ablation in TEC phenocopies the loss of Stat3 expression in these cells.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Limacher et al., Strasbourg, France. In Lancet Oncol, Jan 2016
METHODS: In this phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial, we recruited previously untreated patients aged 18 years or older with stage IV non-small-cell lung cancer without a known activating EGFR mutation and with MUC1 expression in at least 50% of tumoural cells.
Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Ying et al., Beijing, China. In Oncotarget, Jan 2016
UNASSIGNED: To investigate the use of molecular testing on cytological specimens in selecting advanced non-small cell lung cancer (NSCLC) patients who are adequate for targeted treatment, a total of 137 NSCLC cases were analyzed by fluorescence in situ hybridization (FISH) for anaplastic lymphoma kinase (ALK) rearrangements, and Epidermal growth factor receptor (EGFR), kirsten rat sarcoma viral oncogene homolog (KRAS) mutations were evaluated by quantitative real-time PCR (qRT-PCR) platform combining amplification refractory mutation system (ARMS) primers and TaqMan probes.
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
STOP-IgAN Investigators et al., München, Germany. In N Engl J Med, Jan 2016
The primary end points in hierarchical order were full clinical remission at the end of the trial (protein-to-creatinine ratio <0.2 [with both protein and creatinine measured in grams] and a decrease in the estimated glomerular filtration rate [eGFR] of <5 ml per minute per 1.73 m(2) of body-surface area from baseline) and a decrease in the eGFR of at least 15 ml per minute per 1.73 m(2) at the end of the trial.
Characterization of the expression and clinical features of epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in esophageal carcinoma.
Awut et al., Ürümqi, China. In Oncol Lett, Dec 2015
UNASSIGNED: The present study aimed to understand the expression characteristics of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor-2 (VEGFR-2) in individuals of Uygur, Han and Kazak ethnicity with esophageal carcinoma in Xinjiang (China) and their interrelation analysis, and to investigate the expression differences in these genes between esophageal carcinoma and pericarcinoma tissue samples, and between the three ethnic groups.
Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.
Naccarato et al., Pisa, Italy. In Oncol Lett, Dec 2015
The 19 samples were molecularly characterized for mutations in the isocitrate dehydrogenase 1 (IDH1) gene, amplification of the epidermal growth factor receptor (EGFR) gene, presence of the EGFR variant III, and methylation of the promoter region of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene.
Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.
Yuan et al., Hangzhou, China. In Onco Targets Ther, Dec 2015
MPPAC with EGFR mutations can benefit from treatment with EGFR tyrosine kinase inhibitors.
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer.
Garrido-Laguna et al., Salt Lake City, United States. In Onco Targets Ther, Dec 2015
Targeted therapies against EGFR, vascular endothelial growth factor, and vascular endothelial growth factor receptor have expanded treatment options for patients with metastatic colorectal cancer (mCRC).
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Haura et al., Kitakyūshū, Japan. In Plos One, Dec 2015
UNASSIGNED: Epithelial-mesenchymal transition (EMT) is one mechanism of acquired resistance to inhibitors of the epidermal growth factor receptor-tyrosine kinases (EGFR-TKIs) in non-small cell lung cancer (NSCLC).
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.
Phillips et al., Melbourne, Australia. In Lancet Oncol, Dec 2015
Additionally, antibody therapy targeting EGFR may prove effective, although its safety profile in combination with standard chemoradiotherapy has proven to be suboptimal.
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research.
Wang, Edmonton, Canada. In Int J Mol Sci, 2014
In this review, we focus on the transactivation of epidermal growth factor receptor (EGFR), a subfamily of RTKs, by GPCRs.
The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.
Kudo et al., Japan. In Gan To Kagaku Ryoho, 2012
high concentration of gefitinib is not necessary to achieve long-term therapeutic effects in patients with lung adenocarcinoma harboring the EGFR mutation
Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
Pike et al., Saint Louis, United States. In J Biol Chem, 2012
a molecular explanation for the apparent preference of the EGF receptor for dimerizing with ErbB2 and suggest that the phosphorylation of ErbB2 occurs largely in the context of the EGFR/ErbB2 heterodimer
Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.
Wang et al., Beijing, China. In J Clin Oncol, 2012
Chemotherapy may reduce EGFR mutation frequency in patients with non-small cell lung carcinoma, likely the result of a preferential response of subclones with EGFR mutations in tumors with heterogeneous tumor cell populations.
[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
Petera et al., Hradec Králové, Czech Republic. In Strahlenther Onkol, 2012
An increase of EGFR expression during chemoradiation may be associated with significantly shorter DFS and OS.
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
Pichaud et al., London, United Kingdom. In Development, 2012
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
More papers using EGFR antibodies
Emerging roles of Wnts in the adult nervous system.
Katoh Masaru, In PLoS ONE, 2009
... Anti phospho-ERK1/2, antiphospho-EGFR (Tyr1068 and Tyr1086), antiphospho-Akt (S473) and total EGFR antibodies were from Cell Signaling Technology Inc (Danvers, MA, ...
Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report
Hoque Mohammad O., In PLoS ONE, 2009
... CA), ER (SP1, prediluted, Ventana Medical Systems, Tucson, AZ), PR (1E2, prediluted, Ventana Medical Systems), EGFR (3C6, prediluted, Ventana Medical Systems), and HER2 (4B5, prediluted, ...
Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.
Sun Shi-Yong, In PLoS ONE, 2008
Santa Cruz), anti-β-Tubulin and -β-Actin (Sigma-Aldrich); and anti-phospho-EGFR (Y1086, Abcam), and anti-EGFR, -ERK, -Akt ...
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Richardson Andrea L et al., In Breast Cancer Research : BCR, 2008
... USA), CK18 (DC10 antibody, Dako) and CK19 (RCK108 antibody, Dako) as well as for EGFR (EGFR pharmDX kit, Dako) and p53 (DO-7 antibody, ...
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
Smrdel Uros et al., In Journal of Biomedicine and Biotechnology, 2008
... To detect EGFR gene-activating mutations, we used TheraScreen EGFR29 Mutation Kit (DxS Diagnostics, Qiagen, Manchester, UK) ...
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Carvalho Luzia Helena, In PLoS ONE, 2008
... Antibodies to GAPDH, EGFR, MCP-1, and RANTES were purchased from Santa Cruz Biotechnology, Inc ...
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
Domagala Wenancjusz et al., In Virchows Archiv, 2008
... EGFR staining was performed using the EGFR pharmDx kit (Dako) with incubation with proteinase ...
HGF-independent Potentiation of EGFR Action by c-Met
Siegfried Jill M. et al., In Oncogene, 2007
... Mouse anti-c-Met, rabbit anti-EGFR, rabbit anti-Y1234/35-Met and anti-rabbit and anti-mouse-HRP linked secondary antibodies were obtained from Cell Signaling (Beverly, MA) ...
Close-to-native ultrastructural preservation by high pressure freezing
Bergmann Andreas, In PLoS ONE, 2007
... The following EGFR RNAi transgenic lines were used: ...
Lysine acetylation: codified crosstalk with other posttranslational modifications
Sorkin Alexander et al., In The Journal of Cell Biology, 2007
... monoclonal antibody to ubiquitin (P4D1), rabbit polyclonal antibodies to Grb2, Cbl (C-15), Shc (H-108), and EGFR (1005) were purchased from Santa Cruz Biotechnology, Inc ...
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.
Holowka David, In PLoS ONE, 2007
... Cruz Biotechnology, Santa Cruz, CA, USA) and mouse anti-alpha tubulin (Sigma-Aldrich, Milan, Italy) and rabbit anti-EGFR (Cell Signaling Celbio, Milan, Italy) antibodies ...
Neuroprotection and stroke: time for a compromise
Docagne Fabian et al., In The Journal of Experimental Medicine, 2006
... Rabbit anti–mouse pErk1/2 and pAkt and anti–mouse phosphorylated EGFR antibodies were obtained from Cell Signaling Technology ...
Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation.
Munderloh Ulrike Gertrud, In PLoS ONE, 2006
... antibody against phospho-IκBα, IκBα, phospho-IKKα/β, IKKα, IKKβ, phospho-p38, p38, phospho-MKK3/6, MKK3, phospho-Akt, Akt, phospho-EGFR and EGFR were purchased from Cell Signaling (MA, USA) ...
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Waugh M G et al., In Cell Death & Disease, 2006
... Anti-EGFR was from Cell Signaling Technologies (Hertfordshire, UK) and ...
Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung
van Oosterhout Antoon J et al., In Respiratory Research, 2006
... EGFR and phospho-EGFR detected by western blotting using anti-phospho-EGFR (1173 tyrosine residue) and anti-EGFR (Santa Cruz Biotechnology, Santa Cruz, CA) ...
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Wang J M et al., In British Journal of Cancer, 2006
... against phosphorylated Akt, Akt, phosphorylated p38, p38, phosphorylated Erk, Erk, phosphorylated EGFR (tyrosine 992) and EGFR were from Cell Signaling Technology (Beverly, MA, USA) ...
Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.
Lewin Alfred, In PLoS ONE, 2005
... To prepare the substrate for selection, human EGFR-Fc protein was immobilized to Protein G magnetic beads (New England Biolabs, Ipswich, MA) as follows: ...
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cordes Nils, In PLoS ONE, 2005
... indicated suppliers: Cell Signaling Technologies: phospho-IGF-1R (tyrosine 1131/1135/1136), phospho-Akt (Ser 473), Akt, cleaved PARP, phospho-STAT3, EGFR and Akt1; Santa Cruz Biotechnology: IGF-1R, PTK6, Erk2, tubulin; ...
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of Rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Blagosklonny Mikhail V., In PLoS ONE, 2005
... were all obtained from Cell Signaling Technology Inc (Danvers, MA) and anti-p-Tyr-EGFR1173 as well as anti-EGFR were from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
Chen Hong-Chen et al., In Journal of Biomedical Science, 2004
... Monoclonal anti-EGFR (ab30) was purchased from Abcam.
Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables
Wulf Gerburg M et al., In Breast Cancer Research : BCR, 2004
... Phycoerythrin (PE)-conjugated mouse anti-EGFR antibody (EGFR.1,
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Rodemann H Peter et al., In Molecular Cancer, 2004
... The EGFR-inhibitory antibody Erbitux was purchased from Merck KG aA, Germany and ...
Signal transduction for protease-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells
Inagaki Chiyoko et al., In Respiratory Research, 2004
... human TGF-β1 was from Peprotech EC (Margravine Rode, London, UK); antibodies against E-cadherin, GAPDH and phospho-EGFR (specific for Tyr1173) were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, ...
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline
Wells A et al., In British Journal of Cancer, 2004
... Primary antibodies to phospho-EGFR (Cell Signaling, Danvers, MA, USA), ...
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor
Press M F et al., In British Journal of Cancer, 2003
... A polyclonal rabbit antibody to the C-terminus epitope of EGFR was obtained from Santa Cruz Biotechnology, Santa Cruz, CA, USA ...
Label-Free Quantitation of Protein Modifications by Pseudo Selected Reaction Monitoring with Internal Reference Peptides
Ham Amy-Joan L. et al., In Journal of Proteome Research, 2003
For Western blotting, primary antibodies forphosphotyrosine site 1172, phosphotyrosine site 998 and EGFR were purchased from Cell Signaling Technology (Danvers, MA) ...
Expression of luminal and basal cytokeratins in human breast carcinoma
Pogoda Katarzyna et al., In Journal of Neuro-Oncology, 2003
... Immunohistochemistry for cytokeratin 5/6 (Clone D5/16B4, DAKO, dilution scale 1:100), HER1 (EGFR pharm Dx, Clone 2-18C9, DAKO, RTU) and c-KIT (CD117, ...
Age-related changes in VEGF-dependency and angiopoietin-1 induced plasticity of adult blood vessels.
Welm Alana L., In PLoS ONE, 2003
... The antibodies against VEGF (human-specific) and EGFR were purchased from Epitomics Inc ...
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
Hynes Nancy E et al., In Breast cancer research : BCR, 2003
... used in this study: extracellular signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, total β-catenin, poly(ADP-ribose)polymerase (PARP), EGFR, p-EGFR (tyrosine [Tyr] 845), and p-Tyr-100 (Cell Signaling Technology, Inc., Danvers, MA, ...
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Nurminsky Dmitry I., In PLoS ONE, 2002
... (Abcam, ab654), Glut3 (made in Devaskar's lab, UCLA), Glut1 (Abcam, ab15309), IGFR (Cell Signaling, 111A9), EGFR, (Santacruz, sc 03, 1005), Glucose-6-P dehydrogenase (Abcam, ab34436), Protein Kinase C-zeta ...
Can correct protein models be identified?
Jensen-Jarolim Erika et al., In Molecular Immunology, 2002
... removed with xylene from sections and immunohistochemistry was performed using the FDA-approved in vitro diagnostic EGFR pharm Dx™ (DAKO, Glostrup, Denmark) and HercepTest ...
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas: correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients
Saxena Sunita et al., In The Indian Journal of Medical Research, 2002
... the biomarkers- AR (Neomarkers; Fremont, CA, 1:50); ER (DAKO; Denmark, 1:50); PR (DAKO; Denmark, 1:50); EGFR (DAKO; Denmark, 1:50) and CD105 ...
Efficient expression system of human recombinant laminin-5.
Chakravarti Shukti, In PLoS ONE, 2001
... integrin α6 (GoH3); mouse mAbs to integrin α3 (P1B5) and EGFR (528); rabbit pAbs to EGFR (1005), and integrin ß4 (H101) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); ...
Nesca, a novel adapter, translocates to the nuclear envelope and regulates neurotrophin-induced neurite outgrowth
Meakin Susan O. et al., In The Journal of Cell Biology, 2001
... Other primary antibodies used were EGFR and GFP (Santa Cruz Biotechnology, Inc.), phospho-p44/42 MapK (New ...
The investigation of death from diseases caused by coal-burning type of arsenic poisoning
Waalkes Michael P. et al., In Environmental Health Perspectives, 2001
... (sc-1616) and poly-clonal antibodies against cyclin D1 (sc-753), cdk4 (sc-601), and endothelial growth factor receptor (EGFR, sc-03) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Atomic model of the papillomavirus capsid.
Imperiale Michael, In PLoS Pathogens, 2001
... siRNA cell transfection was performed using Lipofectamine 2000 reagent (Invitrogen), with EGFR siRNA (Cell Signaling) according to manufacturer's recommendations ...
Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells
Friess Helmut et al., In Molecular Cancer, 2000
... Phospho-PDGFR-beta (tyr857) and p-EGFR (tyr1173) polyclonal antibodies were purchased from Santa Cruz Biotechnology, Inc ...
Gene Expression Omnibus
Golub Todd R et al., In Genome Biology, 1998
... EGFR and mouse cKIT antibodies were purchased from Santa Cruz Biotechnology [ ...
Protein tyrosine phosphorylation influences adhesive junction assembly and follicular organization of cultured thyroid epithelial cells
Turner T et al., In British Journal of Cancer, 1996
... -catenin, and p120 (Transduction Laboratories, California, USA), phosphorylated MARCKS (Cell Signaling, Massachusetts, USA), phosphorylated EGFR (Cell Signaling, Massachusetts, USA), and EGFR ...
Prevention of radiolysis of monoclonal antibody during labeling
van Dongen Guus A. M. S. et al., In European Journal of Nuclear Medicine and Molecular Imaging, 1995
... MAb cetuximab (Erbitux; 2.0 mg/ml) directed against the epidermal growth factor receptor (EGFR) was purchased from Merck (Darmstadt, Germany) [ ...
The stress activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
Adler G et al., In British Journal of Cancer, 1995
... , and the EGFR were obtained from Santa Cruz Biotechnology (Santa Cruz, USA) ...
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
Poulsen H S et al., In British Journal of Cancer, 1989
... The antiphospho-EGFR (Tyr1086) antibody was from Biosource (USA).Antibody to tubulin was from Santa Cruz Biotechnology Inc ...
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose
Johannes Ludger, In PLoS ONE, 1983
... The following primary antibodies were used: rabbit anti-EGFR antibody (Cell Signaling Technology); rabbit anti-COX IV ...
Nonparametric estimator from incomplete observations.
Minna John D., In PLoS ONE, 1957
... Anti-EGFR (SC-03) antibody from Santa Cruz Biotechnology, Inc ...
share on facebooktweetadd +1mail to friends